Cargando…
COVID-19 manifestations in people with Parkinson’s disease: a USA cohort
BACKGROUND: With the explosion of COVID-19 globally, it was unclear if people with Parkinson’s disease (PD) were at increased risk for severe manifestations or negative outcomes. OBJECTIVES: To report on people with PD who had suspected or confirmed COVID-19 to understand how COVID-19 manifested in...
Autores principales: | Xu, Yaqian, Surface, Matthew, Chan, Amanda K., Halpern, Joshua, Vanegas-Arroyave, Nora, Ford, Blair, Feeney, Megan P., Kwei, Kimberly T., Katus, Linn E., Kuo, Sheng-Han, Shah, Hiral, Waters, Cheryl, Winfield, Linda M., Beck, James C., Przedborski, Serge, Fahn, Stanley, Alcalay, Roy N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418279/ https://www.ncbi.nlm.nih.gov/pubmed/34482434 http://dx.doi.org/10.1007/s00415-021-10784-3 |
Ejemplares similares
-
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
por: Feeney, Megan P., et al.
Publicado: (2021) -
Attitudes Toward Telehealth Services Among People Living With Parkinson's Disease: A Survey Study
por: Xu, Yaqian, et al.
Publicado: (2022) -
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
por: Galper, Jasmin, et al.
Publicado: (2021) -
Lipid level alteration in human and cellular models of alpha synuclein mutations
por: Avisar, Hila, et al.
Publicado: (2022) -
SCARB2 variants and glucocerebrosidase activity in Parkinson’s disease
por: Alcalay, Roy N, et al.
Publicado: (2016)